IN-VITRO AND IN-VIVO CHARACTERIZATION OF NEWLY DEVELOPED IODINATED 1-(2-[BIS(4-FLUOROPHENYL)METHOXY]ETHYL) PIPERAZINE DERIVATIVES IN RATS -LIMITED VALUE AS DOPAMINE TRANSPORTER SPECT LIGANDS
Lj. Rijks et al., IN-VITRO AND IN-VIVO CHARACTERIZATION OF NEWLY DEVELOPED IODINATED 1-(2-[BIS(4-FLUOROPHENYL)METHOXY]ETHYL) PIPERAZINE DERIVATIVES IN RATS -LIMITED VALUE AS DOPAMINE TRANSPORTER SPECT LIGANDS, Synapse, 23(3), 1996, pp. 201-207
A series of 1-{2-[bis(4-fluorophenyl)methoxy]ethyl}piperazines (CYD1,
2, 3, 5) with a 4-substituent incorporating a 1-hydroxy-3-iodo-2-prope
nyl moiety, except CYD2 which lacks the hydroxy, was synthesized as po
tential in vivo imaging ligands for the dopamine transporter. For two
of the piperazine derivatives (CYD3 and 5), possible stereoselectivity
was considered as well (both E- and Z-form). Their in vitro potency f
or inhibition of [H-3]dopamine uptake in rat striatal synaptosomes was
10-fold lower than that of GBR 12909 used as a reference. The highest
K-i values were 137 and 101 nM for CYD1E and CYD3E, respectively. Inh
ibition potency was higher for the E- than for the Z-isomers. In vivo
distribution of radioactivity in rats injected with the I-123-labeled
CYDs showed preferred striatal uptake for CYD1E and CYD3E as compared
to the cerebellum and occipital cortex. Although the E-isomer of CYD3
showed the best in vitro and in vivo binding characteristics, its stri
atal uptake ratios (maximal value: 2.7 for striatum-to-cerebellum at 4
h p.i.) are too low to consider application in human Single Photon Em
ission Computed Tomography studies. (C) 1996 Wiley-Liss, Inc.